Ophthalmic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Ophthalmic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Ophthalmic Devices Market by Product Type (Surgical Devices [Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Glaucoma Drainage Devices, Vitrectomy Systems, Excimer Lasers, Photocoagulation Lasers, and Others], Diagnostic and Monitoring Devices [Optical Coherence Tomography Systems, Ophthalmic Ultrasound Systems, Fundus Cameras, Slit Lamps, Corneal Topography Systems, and Others], Lenses [Intraocular Lenses, Contact Lenses [Soft Contact Lenses and Rigid Gas Permeable Contact Lenses], Spectacle Lenses, and Others], and Others), Application (Glaucoma, Cataract, Retinopathies, Age-Related Macular Degeneration, Myopia, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the growing cases of eye-related disorders and increasing government initiatives to improve eye health worldwide

The ophthalmic devices market was valued at USD 53.72 billion in 2023, growing at a CAGR of 4.12% during the forecast period from 2024 to 2030 to reach USD 67.99 billion by 2030. The ophthalmic devices market is expanding rapidly due to the increasing incidence of eye-related disorders such as myopia, and astigmatism, increasing government initiatives to improve eye health, growing geriatric population, among others that are expected to escalate the overall ophthalmic devices market during the forecast period from 2024 to 2030.

Ophthalmic Devices Market Dynamics:

According to Vision Center (2024), currently, late teenagers and young adults in countries like Korea, Taiwan, and China suffer myopia prevalence rates ranging from 84% to 97% on average. Globally, approximately 224 million individuals, constituting nearly 3% of the population, suffer from severe myopia. The projections for 2050 are more alarming, with almost half of the world's population, constituting 5 billion people expected to be myopic. The prevalence of high myopia is anticipated to elevate for almost 10% of the global population by 2050, translating to around 1 billion individuals at risk of permanent vision impairment. The global condition of myopia, or near-sightedness, is affecting millions and is on the rise due to trends in urbanization and digitalization. This increase led researchers and healthcare professionals to explore the causes, effects, and solutions to this issue. As more people become myopic, there will be a greater need for regular eye exams to diagnose the condition.

Furthermore, government initiatives aimed at enhancing eye health, coupled with advancements in ophthalmology technology, are driving the market growth. For instance, in August 2022, The International Agency for the Prevention of Blindness (IAPB), launched a global awareness campaign by emphasizing the importance of eye care, for approximately 1 billion people worldwide lacking access to treatment for poor vision. As awareness grows about the importance of regular eye exams in maintaining eye health, there will be an increase in the number of individuals seeking eye care services. This rise in demand for eye examinations will consequently lead to an increased demand for ophthalmic devices, which are essential tools used by eye care professionals to assess refractive errors and other eye conditions during these exams.

The World Health Organization (2021) further stated that between 2015 to 2050, people above 60 years of age will be doubled from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will be aged 60 years or above. As people age, they are more likely to develop presbyopia. Ophthalmic devices are essential in detecting and managing age-related vision conditions like presbyopia. They help assess the eye's ability to focus, enabling precise prescriptions for corrective lenses and monitoring changes in vision over time.

Therefore, the factors stated above collectively will drive the overall ophthalmic devices market growth.

However, inconsistent readings associated with the use of ophthalmic devices, advancements in telemedicine and remote eye examinations, and others may prove to be challenging factors for ophthalmic device market growth.

Ophthalmic Devices Market Segment Analysis:

Ophthalmic Devices Market by Product Type (Surgical Devices [Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Glaucoma Drainage Devices, Vitrectomy Systems, Excimer Lasers, Photocoagulation Lasers, and Others], Diagnostic and Monitoring Devices [Optical Coherence Tomography Systems, Ophthalmic Ultrasound Systems, Fundus Cameras, Slit Lamps, Corneal Topography Systems, and Others], Lenses [Intraocular Lenses, Contact Lenses [Soft Contact Lenses and Rigid Gas Permeable Contact Lenses], Spectacle Lenses, and Others], and Others), Application (Glaucoma, Cataract, Retinopathies, Age-Related Macular Degeneration, Myopia, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the ophthalmic devices market, the glaucoma drainage devices subcategory of surgical device category is expected to have a significant revenue share in the year 2023. This is because of the rising prevalence of glaucoma conditions due to increased production of aqueous humor, genetic predisposition to the condition, and other medical conditions worldwide. According to the latest data provided by the Glaucoma Research Foundation (2022), it was stated that about 80 million people were living with glaucoma worldwide with projections indicating that the stats will rise to 22 million individuals by 2040.

These devices consist of a small tube that is implanted in the eye to help drain excess aqueous humor, thereby reducing intraocular pressure (IOP). Key features of these devices include their ability to provide long-term pressure control and their compatibility with a variety of patient conditions, including those who have undergone multiple eye surgeries or have complex glaucoma cases. They are designed to minimize postoperative complications, such as hypotony (excessively low IOP), and often include mechanisms to regulate fluid flow to prevent sudden drops in pressure.

Additionally, the market key market players involved in product launches, product approvals, mergers, acquisitions, and other activities further boost the market of glaucoma drainage devices across the world. For instance, in October 2022, Alcon, the world leader in eye care committed to enabling people to see brilliantly, announced the completion of its previously announced acquisition of Ivantis®, maker of the ground-breaking Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) tool intended to reduce eye pressure for open-angle glaucoma patients in conjunction with cataract surgery.

Therefore the widespread uses and various advantages of glaucoma drainage devices enhance performance and usability, solidifying the significant impact on the growth of the overall ophthalmic devices market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall ophthalmic devices market:

Among all the regions, North America is expected to dominate the ophthalmic devices market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This is driven by the presence of a significant number of eye care professionals and clinics, including optometrists, ophthalmologists, and eye care centers, a large patient pool associated with vision loss, hypermetropia, and astigmatism, the presence of a developed & sophisticated healthcare infrastructure, and product developmental activities are factors that drive the expansion of the ophthalmic devices market in the North America region during the forecast period from 2024 to 2030.

According to the American Academy of Ophthalmology (2024), 33% of people in the US have astigmatism. Astigmatism affects people of all ages and races. Babies may even have astigmatism, although most soon outgrow it. Additionally, it stated that 14 million Americans aged 40 and above are affected with hypermetropia. Ophthalmic devices are essential in diagnosing and managing astigmatism and hypermetropia by analyzing how light interacts with the eye. Refractometers and autorefractors measure light refraction to detect vision imperfections, while corneal topography maps the curvature of the cornea to identify irregularities. Phoropters are used during eye exams to determine the correct lens prescription, aiding in the treatment of these conditions.

According to statistics unveiled by the Canadian Council of the Blind in February 2022, approximately 1.2 million Canadians suffered vision loss in 2020. Projections for the year 2030 estimate that this figure will surge to 1.58 million. Such increase in the number of cases of vision impairment are anticipated to fuel the uptake of visual impairment devices, consequently influencing market dynamics in the region. As awareness of eye health grows in response to the rising prevalence of vision loss, there may be a greater emphasis on preventive care and early detection of eye conditions. Ophthalmic devices play a vital role in vision loss and improving eye health. These devices are used for early detection, diagnosis, and treatment of eye conditions, helping to prevent further deterioration and improve the quality of life for individuals with visual impairments. As awareness of eye health increases, the demand for these devices is expected to grow, enhancing the overall approach to eye care and preventive measures in the region.

Rising product developmental activities by regulatory bodies and key players in the region will further boost the market for ophthalmic devices. For example, in October 2021, iCare USA received the 510k approval from the U.S Food and Drug Administration for their EIDON Ultra-Widefield Lens module which is capable of capturing 120 degrees images of the retina in a single shot or in mosaic function mode, images up to 200 degrees.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American ophthalmic devices market.

Ophthalmic Devices Market key players:

Some of the key market players operating in the ophthalmic devices market include Johnson & Johnson Services, Inc., Baxter, CANON MEDICAL SYSTEMS EUROPE B.V., CooperVision Inc., Alcon Inc., Bausch & Lomb, Inc., OMRON Corporation, Ziemer Ophthalmic Systems AG, Essilor Instruments USA Ltd., Konan Medical USA, Inc., Optovue Incorporated, NIDEK CO. LTD., ZEISS Group, Luneau Technology Group, OPTOPOL Technology Sp. z o.o., Rudolf Riester GmbH, Rexxam Co. Ltd., Keeler, Sonomed Escalon, STAAR Surgical, and others.

Recent Developmental Activities in the Ophthalmic Devices Market:

• In February 2024, RetinAI, a provider of software solutions for image processing and artificial intelligence in ophthalmology, introduced the RetinAI Discovery for Clinics platform. The platform was launched in both ophthalmology and optometry versions.
• In November 2023, Lumenis announced the launch of OptiPlus, its new dual-frequency radiofrequency device designed to deliver heat across various tissue layers, aimed at increasing blood circulation and addressing dry eye inflammation caused by meibomian gland dysfunction.
• In October 2021, NIDEK CO LTD. launched the Retina Scan Duo 2, a combined OCT and fundus camera system. The system comes equipped with new features designed to enhance screening and clinical efficiency.
• In May 2021, Essilor International received the product approval from the US FDA for their product Essilor Stellest which is a spectacle lens developed for the correction of myopia and slowing down myopia progression in children.

Key Takeaways from the Ophthalmic Devices Market Report Study

• Market size analysis for current ophthalmic devices market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the ophthalmic devices market.
• Various opportunities available for the other competitors in the ophthalmic devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current ophthalmic devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for ophthalmic devices market growth in the coming future?

Target Audience who can be benefited from this Ophthalmic Devices Market Report Study

• Ophthalmic devices product providers
• Research organizations and consulting companies
• Ophthalmic devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in ophthalmic devices
• Various end-users who want to know more about the ophthalmic devices market and the latest technological developments in the ophthalmic devices market

Frequently Asked Questions for the Ophthalmic Devices Market:

1. What are Ophthalmic Devices?

The ophthalmic devices help in the diagnosis and treatment of ocular diseases by helping in the visualization of the anatomy of eye and treating the indication in by being utilized in different aspects of disease diagnosis and treatment.

2. What is the market for Ophthalmic Devices?

The ophthalmic devices market was valued at USD 53.72 billion in 2023, growing at a CAGR of 4.12% during the forecast period from 2024 to 2030 to reach USD 67.99 billion by 2030.

3. What are the drivers for the Ophthalmic Devices market?

The ophthalmic devices market is expanding rapidly due to the increasing incidence of eye-related disorders such as myopia, and astigmatism, increasing government initiatives to improve eye health, growing geriatric population, among others that are expected to escalate the overall ophthalmic devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Ophthalmic Devices market?

Some of the key market players operating in ophthalmic devices include Johnson & Johnson Services, Inc., Baxter, CANON MEDICAL SYSTEMS EUROPE B.V., CooperVision Inc., Alcon Inc., Bausch & Lomb, Inc., OMRON Corporation, Ziemer Ophthalmic Systems AG, Essilor Instruments USA Ltd., Konan Medical USA, Inc., Optovue Incorporated, NIDEK CO. LTD., ZEISS Group, Luneau Technology Group, OPTOPOL Technology Sp. z o.o., Rudolf Riester GmbH, Rexxam Co. Ltd., Keeler, Sonomed Escalon, STAAR Surgical, and others.

5. Which region has the highest share in the Ophthalmic Devices market?

North America is expected to dominate the overall ophthalmic devices market during the forecast period from 2024 to 2030. This is driven by the presence of a significant number of eye care professionals and clinics, including optometrists, ophthalmologists, and eye care centers, a large patient pool associated with vision loss, hypermetropia, and astigmatism, the presence of a developed & sophisticated healthcare infrastructure, and product developmental activities are factors that drive the expansion of the ophthalmic devices market in the North America region during the forecast period from 2024 to 2030.